Cyclosporin nanoparticulate lipospheres for oral administrationBEKERMAN, Tania; GOLENSER, Jacob; DOMB, Abraham et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 5, pp 1264-1270, issn 0022-3549, 7 p.Article

Preparation and Enhancement of Oral Bioavailability of Curcumin Using Microemulsions VehicleLIANDONG HU; YANHONG JIA; FENG NIU et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 29, pp 7117-7121, issn 0021-8561, 5 p.Article

Preparation, characterization and in vivo studies of proliposomes containing cyclosporine aSHAH, Neha M; PARIKH, Jolly; NAMDEO, Alok et al.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 2967-2973, issn 1533-4880, 7 p.Article

Pharmacokinetics of orally administered melatonin in critically ill patientsMISTRALETTI, Giovanni; SABBATINI, Giovanni; FRASCHINI, Franco et al.Journal of pineal research. 2010, Vol 48, Num 2, pp 142-147, issn 0742-3098, 6 p.Article

Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex techniqueJINGHUARUAN; JIE LIU; DIZHU et al.International journal of pharmaceutics (Print). 2010, Vol 386, Num 1-2, pp 282-290, issn 0378-5173, 9 p.Article

Influence of Gastrointestinal Digestion and Edible Plant Combination on Oral Bioavailability of Triterpene Saponins, Using a Biomimetic Digestion and Absorption System and Determination by HPLCLI, Shun-Xing; YANG MU; ZHENG, Feng-Ying et al.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 44, pp 10599-10603, issn 0021-8561, 5 p.Article

Application of nanostructured lipid carrier in food for the improved bioavailabilityLIU, G. Y; WANG, J. M; XIA, Q et al.European food research & technology (Print). 2012, Vol 234, Num 3, pp 391-398, issn 1438-2377, 8 p.Article

A Formulation-Enabled Preclinical Efficacy Assessment of a Farnesoid X Receptor Agonist, GW4064, in Hamsters and Cynomolgus MonkeysCHIANG, Po-Chang; THOMPSON, David C; GHOSH, Sarbani et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 11, pp 4722-4733, issn 0022-3549, 12 p.Article

Excretion of the Principal Urinary Metabolites of Phenytoin and Absolute Oral Bioavailability Determined by Use of a Stable Isotope in Patients With EpilepsyALIWARGA, Theresa; CLOYD, James C; GOEL, Varun et al.Therapeutic drug monitoring. 2011, Vol 33, Num 1, pp 56-63, issn 0163-4356, 8 p.Article

P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexoneKANAAN, Mouna; DAALI, Youssef; DAYER, Pierre et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 5, pp 543-548, issn 0767-3981, 6 p.Article

Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery SystemWEILUN KE; YANSONG ZHAO; RONGQIN HUANG et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 6, pp 2208-2216, issn 0022-3549, 9 p.Article

Effects of Estrogen and Estrus Cycle on Pharmacokinetics, Absorption, and Disposition of Genistein in Female Sprague―Dawley RatsKULKARNI, Kaustubh H; ZHEN YANG; TAO NIU et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 32, pp 7949-7956, issn 0021-8561, 8 p.Article

Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicellesSHIXIAO JIN; SHANSHAN FU; JIN HAN et al.Journal of drug targeting. 2012, Vol 20, Num 7, pp 615-622, issn 1061-186X, 8 p.Article

Bloat free Genetic Programming: application to human oral bioavailability predictionSILVA, Sara; VANNESCHI, Leonardo.International journal of data mining and bioinformatics (Print). 2012, Vol 6, Num 6, pp 585-601, issn 1748-5673, 17 p.Article

Quantification of trans-3,4,5,4'-Tetramethoxystilbene in Rat Plasma by HPLC: Application to Pharmacokinetic StudyLIN, Hai-Shu; WEI ZHANG; MEI LIN GO et al.Journal of agricultural and food chemistry (Print). 2011, Vol 59, Num 4, pp 1072-1077, issn 0021-8561, 6 p.Article

Antacid Use and Reduced Bioavailability of Oral Drugs Case studies, overview and perspectivesSRINIVAS, Nuggehally R.Arzneimittel-Forschung. 2009, Vol 59, Num 7, pp 327-334, issn 0004-4172, 8 p.Article

Contribution of Formulation and Excipients Towards Enhanced Permeation of CurcuminWAHLANG, B; KABRA, D; PAWAR, Y. B et al.Arzneimittel-Forschung. 2012, Vol 62, Num 2, pp 88-93, issn 0004-4172, 6 p.Article

Novel nanoemulsion for minimizing variations in bioavailability of ezetimibeBALI, Vikas; ALI, Mushir; ALI, Javed et al.Journal of drug targeting. 2010, Vol 18, Num 7, pp 506-519, issn 1061-186X, 14 p.Article

Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailabilityLAPPIN, Graham; SHISHIKURA, Yoko; JOCHEMSEN, Roeline et al.European journal of pharmaceutical sciences. 2010, Vol 40, Num 2, pp 125-131, issn 0928-0987, 7 p.Article

A bioavailability study comparing two oral formulations containing zinc (zn bis-glycinate vs. zn gluconate) after a single administration to twelve healthy female volunteersGANDIA, Peggy; BOUR, Dorothée; MAURETTE, Jean-Marc et al.International journal for vitamin and nutrition research. 2007, Vol 77, Num 4, pp 243-248, issn 0300-9831, 6 p.Article

Oral Bioavailability, Urinary Excretion and Organ Distribution of Melamine in Sprague-Dawley Rats by High-Performance Liquid Chromatography with Tandem Mass SpectrometryWU, Yu-Tse; HUANG, Chih-Min; LIN, Chia-Chun et al.Journal of agricultural and food chemistry (Print). 2010, Vol 58, Num 1, pp 108-111, issn 0021-8561, 4 p.Article

The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics : The traditional equation may considerably overestimate the true valueBEREZHKOVSKIY, Leonid M.Journal of pharmaceutical sciences. 2006, Vol 95, Num 4, pp 834-848, issn 0022-3549, 15 p.Article

Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classesDARWICH, Adam S; HENDERSON, Kathryn; BURGIN, Angela et al.British journal of clinical pharmacology. 2012, Vol 74, Num 5, pp 774-787, issn 0306-5251, 14 p.Article

Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass MetabolismTREVASKIS, Natalie L; SHACKLEFORD, David M; CHARMAN, William N et al.Pharmaceutical research. 2009, Vol 26, Num 6, pp 1486-1495, issn 0724-8741, 10 p.Article

A convenient method for estimating the quantity of drug eliminated by the routes other than hepatic metabolism and renal excretion and the fraction of drug that reaches the first pass after oral administrationBEREZHKOVSKIY, Leonid M.Journal of pharmaceutical sciences. 2006, Vol 95, Num 4, pp 828-833, issn 0022-3549, 6 p.Article